Multi-omic profiling of LXR activation identifies SLPG as a sterol-inducible lysoplasmalogenase in macrophages
Estimating the magnitude of LDL-C reduction needed to overcome the increased risk of atherosclerotic cardiovascular events caused by LP(A) to guide clinical management
Silencing of ANGPTL4 via antisense oligonucleotides effectively reduces plasma triglyceride and glucose levels in mice without causing lymphadenopathy
